Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MitoTEMPOL

Catalog No. T35965 Copy Product Info
Purity: 98.06%
🥰Excellent
MitoTEMPOL is a mitochondria-targeted antioxidant that prevents septal dysfunction by reversing sepsis-induced decreases in mitochondrial function, activation of protein hydrolysis pathways, and reductions in myosin heavy chain content, as well as eliminating cytokine-induced increases in muscle cell superoxide production and decreases in cell size.

MitoTEMPOL

Copy Product Info
🥰Excellent
Catalog No. T35965

MitoTEMPOL is a mitochondria-targeted antioxidant that prevents septal dysfunction by reversing sepsis-induced decreases in mitochondrial function, activation of protein hydrolysis pathways, and reductions in myosin heavy chain content, as well as eliminating cytokine-induced increases in muscle cell superoxide production and decreases in cell size.

MitoTEMPOL
Cas No. 1101113-39-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$61In StockIn Stock
5 mg$147In StockIn Stock
10 mg$239-In Stock
25 mg$479-In Stock
50 mg$687-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.06%
Appearance:Viscous
Color:Orange
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
MitoTEMPOL is a mitochondria-targeted antioxidant that prevents septal dysfunction by reversing sepsis-induced decreases in mitochondrial function, activation of protein hydrolysis pathways, and reductions in myosin heavy chain content, as well as eliminating cytokine-induced increases in muscle cell superoxide production and decreases in cell size.
In vitro
MitoTEMPOL exhibits mitochondria-targeted antioxidant activity, relying on its reaction with ubiquinol to form the corresponding hydroxylamine, and demonstrates superior membrane-associated reactivity compared to non-targeted piperidine nitroxides.
Chemical Properties
Molecular Weight583.56
FormulaC32H42BrNO2P
Cas No.1101113-39-6
Smiles[Br-].[O]N1C(C)(C)CC(OCCCCC[P+](C=2C=CC=CC2)(C=3C=CC=CC3)C=4C=CC=CC4)CC1(C)C
Relative Density.no data available
Storage & Solubility Information
StorageShipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMF: 40 mg/mL (68.54 mM), Sonication is recommended.
PBS (pH 7.2): 10 mg/mL (17.14 mM), Sonication is recommended.
DMSO: 40 mg/mL (68.54 mM), Sonication is recommended.
Ethanol: 40 mg/mL (68.54 mM), Sonication is recommended.
Solution Preparation Table
PBS (pH 7.2)/DMF/DMSO/Ethanol
1mg5mg10mg50mg
1 mM1.7136 mL8.5681 mL17.1362 mL85.6810 mL
5 mM0.3427 mL1.7136 mL3.4272 mL17.1362 mL
10 mM0.1714 mL0.8568 mL1.7136 mL8.5681 mL
DMF/DMSO/Ethanol
1mg5mg10mg50mg
20 mM0.0857 mL0.4284 mL0.8568 mL4.2840 mL
50 mM0.0343 mL0.1714 mL0.3427 mL1.7136 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MitoTEMPOL | purchase MitoTEMPOL | MitoTEMPOL cost | order MitoTEMPOL | MitoTEMPOL chemical structure | MitoTEMPOL in vitro | MitoTEMPOL formula | MitoTEMPOL molecular weight